Fingerprint
Dive into the research topics of 'A Phase I Dose-Escalation and Dose-Expansion Study of FCN-437c, a Novel CDK4/6 Inhibitor, in Patients with Advanced Solid Tumors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A Phase I Dose-Escalation and Dose-Expansion Study of FCN-437c, a Novel CDK4/6 Inhibitor, in Patients with Advanced Solid Tumors
Amita Patnaik, Erika Hamilton, Yan Xing, Drew W. Rasco, Lon Smith, Ya Li Lee, Steven Fang, Jiao Wei, Ai Min Hui
Research output: Contribution to journal › Article › peer-review